← Leaderboards
Yongsheng Shi
Pennsylvania State University, The
$11,505,841
Attributed
$18,589,698
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,589,698 · 14
By mechanism
R01$16,126,399 · 7
R35$1,600,227 · 1
R21$431,750 · 1
T32$275,813 · 1
F32$141,700 · 1
P41$13,809 · 3
Top collaborators
- Roger Sciammas7 shared
- Bert L. Semler7 shared
- Rozanne M. Sandri-Goldin6 shared
- Robert Andrew Edwards5 shared
- Paul D Gershon5 shared
- Klemens J Hertel5 shared
- Yingwei Mao5 shared
- Marian L Waterman5 shared
Most similar at Pennsylvania State University, The
Same institution · by research overlap
- Yingwei Mao$2,100,497
- Maria-Eirini Pandelia$3,127,436
Others in their field
Top investigators on “Messenger Rna”
- Jeffrey P Krischer · University Of South Florida$206,732,287
- David Heimbrook · Leidos Biomedical Research, Inc.$96,474,613
- Henry F Chambers · Duke University$47,759,573
- Vance G Fowler · Duke University$46,487,462
- Barton F Haynes · Duke University$43,472,529
- Bradley F Boeve · Mayo Clinic Rochester$42,990,413
Research focus
Messenger RnaInsightPlayComplexGenesProteinsRegulationPolyadenylationTranslationsGene ExpressionMalignant NeoplasmsCellsRna-Binding ProteinsMolecularPatternRna SplicingProtein IsoformsGene Expression RegulationBasePublishingBiochemicalNovel TherapeuticsHuman DiseaseMrna Stability
Grant awards (59)
mRNA alternative polyadenylation in B cell development$768,845
R01 · FY2025 · AI · contact PI
Decode polyadenylation in health and disease$667,379
R01 · FY2025 · CA · contact PI
Mechanisms and regulation of mRNA 3' processing$479,905
R35 · FY2025 · GM · contact PI
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells$465,684
R01 · FY2025 · AI
mRNA alternative polyadenylation in B cell development$20,498
R01 · FY2025 · AI · contact PI
mRNA alternative polyadenylation in B cell development$773,817
R01 · FY2024 · AI · contact PI
Mechanisms and regulation of mRNA 3' processing$479,905
R35 · FY2024 · GM · contact PI
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells$465,684
R01 · FY2024 · AI
Translational control in neurogenesis by ZNF804A$271,878
R01 · FY2024 · MH
Virus-host interactions: a multi-scale training program$137,020
T32 · FY2024 · AI
mRNA alternative polyadenylation in B cell development$86,698
R01 · FY2024 · AI · contact PI
Mechanisms and regulation of mRNA 3' processing$77,105
R35 · FY2024 · GM · contact PI
mRNA alternative polyadenylation in B cell development$776,774
R01 · FY2023 · AI · contact PI
Mechanisms and regulation of mRNA 3' processing$479,905
R35 · FY2023 · GM · contact PI
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells$465,684
R01 · FY2023 · AI
Translational control in neurogenesis by ZNF804A$271,878
R01 · FY2023 · MH
Virus-host interactions: a multi-scale training program$138,793
T32 · FY2023 · AI
Mechanisms and regulation of mRNA 3' processing$83,407
R35 · FY2023 · GM · contact PI
mRNA alternative polyadenylation in B cell development$66,200
R01 · FY2023 · AI · contact PI
mRNA alternative polyadenylation in B cell development$793,986
R01 · FY2022 · AI · contact PI
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells$465,684
R01 · FY2022 · AI
Characterization of the mammalian mRNA 3'-end processing complex$318,270
R01 · FY2022 · GM · contact PI
Translational control in neurogenesis by ZNF804A$271,878
R01 · FY2022 · MH
Molecular basis of the anti-cancer and anti-inflammation activities of JTE607$196,250
R21 · FY2022 · AI · contact PI
Characterization of the mammalian mRNA 3'-end processing complex$133,189
R01 · FY2022 · GM · contact PI
Nuclear functions co-opted by human rhinovirus during replication in the cytoplasm of infected cells$462,544
R01 · FY2021 · AI
Translational control in neurogenesis by ZNF804A$424,071
R01 · FY2021 · MH
Herpes simplex virus-mediated regulation of host gene expression$350,663
R01 · FY2021 · GM · contact PI
Characterization of the mammalian mRNA 3'-end processing complex$318,270
R01 · FY2021 · GM · contact PI
Molecular basis of the anti-cancer and anti-inflammation activities of JTE607$235,500
R21 · FY2021 · AI · contact PI
Translational control in neurogenesis by ZNF804A$465,831
R01 · FY2020 · MH
Herpes simplex virus-mediated regulation of host gene expression$350,663
R01 · FY2020 · GM · contact PI
Characterization of the mammalian mRNA 3'-end processing complex$318,270
R01 · FY2020 · GM · contact PI
Herpes simplex virus-mediated regulation of host gene expression$112,810
R01 · FY2020 · GM · contact PI
Herpes simplex virus-mediated regulation of host gene expression$350,663
R01 · FY2019 · GM · contact PI
Characterization of the mammalian mRNA 3'-end processing complex$318,270
R01 · FY2019 · GM · contact PI
Herpes simplex virus-mediated regulation of host gene expression$61,352
R01 · FY2019 · GM · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$475,840
R01 · FY2018 · CA
Herpes simplex virus-mediated regulation of host gene expression$350,663
R01 · FY2018 · GM · contact PI
Characterization of the mammalian mRNA-3'-end processing complex$300,669
R01 · FY2018 · GM · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$475,840
R01 · FY2017 · CA
Characterization of the mammalian mRNA-3'-end processing complex$301,142
R01 · FY2017 · GM · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$475,840
R01 · FY2016 · CA
Characterization of the mammalian mRNA-3'-end processing complex$301,587
R01 · FY2016 · GM · contact PI
Characterization of the mammalian mRNA-3'-end processing complex$150,276
R01 · FY2016 · GM · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$472,634
R01 · FY2015 · CA
Characterization of the mammalian mRNA-3'-end processing complex$302,008
R01 · FY2015 · GM · contact PI
Coordinated regulation of alternative pre-mRNA processing in colon cancer$469,833
R01 · FY2014 · CA
Characterization of the mammalian mRNA 3???-end processing complex$286,876
R01 · FY2014 · GM · contact PI
Characterization of the mammalian mRNA 3???-end processing complex$277,777
R01 · FY2013 · GM · contact PI
Characterization of the mammalian mRNA 3???-end processing complex$288,717
R01 · FY2012 · GM · contact PI
Characterization of the mammalian mRNA 3???-end processing complex$289,482
R01 · FY2011 · GM · contact PI
Characterization of the mammalian mRNA 3???-end processing complex$289,782
R01 · FY2010 · GM · contact PI
PROTEOMIC ANALYSIS OF THE EUKARYOTIC PRE-MRNA 3' PROCESSING COMPLEX$2,425
P41 · FY2010 · RR · contact PI
PROTEOMIC ANALYSIS OF THE EUKARYOTIC PRE-MRNA 3' PROCESSING COMPLEX$3,309
P41 · FY2009 · RR · contact PI
PROTEOMIC ANALYSIS OF THE EUKARYOTIC PRE-MRNA 3' PROCESSING COMPLEX$8,075
P41 · FY2008 · RR · contact PI
Phosphorylation regulation of SRp38 by cell signaling$50,428
F32 · FY2006 · GM · contact PI
Phosphorylation regulation of SRp38 by cell signaling$48,296
F32 · FY2005 · GM
Phosphorylation regulation of SRp38 by cell signaling$42,976
F32 · FY2004 · GM